This information was published, 2016-01-13 14:10 CET (GLOBE NEWSWIRE) —
Episurf Medical AB has appointed Pareto Securities as market maker for its share, which is listed on Nasdaq Stockholm. The purpose is to reduce the difference between bid and ask price and increase the liquidity of the share.
‘The market making provides Episurf with a higher share liquidity, which gives a more accurate valuation and a lower risk premium for our investors’, says Episurf’s CFO, Pål Ryfors.
The market making agreement is effective as of January 15, 2016.
Stockholm, January 13 2016
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are in development for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system will enable implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention.
Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. The information in this press release is such that Episurf Medical AB is required to disclose in accordance with the Securities Markets Act and/or the Financial Instruments Trading Act.
For more information, please contact:
Rosemary Cunningham Thomas, CEO, Episurf Medical
Tel: +46 (0) 70-7655892
Tel: +44 (0) 7803-753603